Predictive Oncology Inc. Quarterly Earnings Per Share, Diluted in USD/shares from Q2 2018 to Q3 2022

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Summary
Predictive Oncology Inc. quarterly Earnings Per Share, Diluted history and growth rate from Q2 2018 to Q3 2022.
  • Predictive Oncology Inc. Earnings Per Share, Diluted for the quarter ending September 30, 2022 was -0.05 USD/shares, a 37.5% increase year-over-year.
Earnings Per Share, Diluted, Quarterly (USD/shares)
Earnings Per Share, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $0 +$0.03 +37.5% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $0 $0 -200% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-11
Q3 2021 $0 +$0.38 +82.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $0 +$0.31 +86.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q3 2020 $0 Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $0 -$1 -250% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q2 2019 $0.24 +$0.44 Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q2 2018 $0 Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.